SEARCH

SEARCH BY CITATION

References

  • Alessandri G., Cornaglia Ferraris P. and Gullino P. M. (1997) Angiogenic and angiostatic microenvironment in tumors – role of gangliosides. Acta Oncol. 36, 383387.
  • Bai H. and Seyfried T. N. (1997) Influence of ganglioside GM3 and high density lipoprotein (HDL) on the cohesion of mouse brain tumor cells. J. Lipid Res. 38, 160172.
  • Berra B., Gaini S. M. and Riboni L. (1985) Correlation between ganglioside distribution and histological grading of human astrocytomas. Int. J. Cancer 36, 363366.
  • Birkle S., Zeng G., Gao L., Yu R. K. and Aubry J. (2003) Role of tumor-associated gangliosides in cancer progression. Biochimie 85, 455463.
  • Bos R., Van Diest P. J., De Jong J. S., Van Der Groep P., Van Der Valk P. and Van Der Wall E. (2005) Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology 46, 3136.
  • Chaudhry I. H., O'Donovan D. G., Brenchley P. E., Reid H. and Roberts I. S. (2001) Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas. Histopathology 39, 409415.
  • Claffey K. P., Brown L. F., Del Aguila L. F., Tognazzi K., Yeo K. T., Manseau E. J. and Dvorak H. F. (1996) Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res. 56, 172181.
  • Claffey K. P., Abrams K., Shih S. C., Brown L. F., Mullen A. and Keough M. (2001) Fibroblast growth factor 2 activation of stromal cell vascular endothelial growth factor expression and angiogenesis. Laboratory Invest. 81, 6175.
  • Ding H., Wu X., Roncari L., Lau N., Shannon P., Nagy A. and Guha A. (2000) Expression and regulation of neuropilin-1 in human astrocytomas. Int. J. Cancer 88, 584592.
  • Ecsedy J. A., Yohe H. C., Bergeron A. J. and Seyfried T. N. (1998) Tumor-infiltrating macrophages contribute to the glycosphinglipid composition of brain tumors. J. Lipid Res. 39, 22182227.
  • El-Abbadi M. and Seyfried T. N. (1994) Influence of growth environment on the ganglioside composition of an experimental mouse brain tumor. Mol. Chem. Neuropathol. 21, 273285.
  • Ferrara N. and Davis Smyth T. (1997) The biology of vascular endothelial growth factor. Endocr. Rev. 18, 425.
  • Flavin H. J., Wieraszko A. and Seyfried T. N. (1991) Enhanced aspartate release from hippocampal slices of epileptic (El) mice. J. Neurochem. 56, 10071011.
  • Folch J., Lees M. and Sloane-Stanley G. H. (1957) A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226, 497509.
  • Furukawa K. and Takamiya K. (2002) Beta1,4-N-acetylgalactosaminyltransferase – GM2/GD2 synthase: a key enzyme to control the synthesis of brain-enriched complex gangliosides. Biochim. Biophys. Acta 1573, 356362.
  • Goldman C. K., Kim J., Wong W. L., King V., Brock T. and Gillespie G. Y. (1993) Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol. Biol. Cell 4, 121133.
  • Hakomori S. (2002) Glycosylation defining cancer malignancy: New wine in an old bottle. Proc. Natl Acad. Sci. USA 99, 10 23110 233.
  • Herold-Mende C., Steiner H. H., Andl T., Riede D., Buttler A., Reisser C., Fusenig N. E. and Mueller M. M. (1999) Expression and functional significance of vascular endothelial growth factor receptors in human tumor cells. Laboratory Invest. 79, 15731582.
  • Kaur B., Khwaja F. W., Severson E. A., Matheny S. L., Brat D. J. and Van Meir E. G. (2005) Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro-Oncol. 7, 134153.
  • Keenan T. W., Morre D. J. and Basu S. (1974) Ganglioside biosynthesis. Concentration of glycosphingolipid glycosyltransferases in Golgi apparatus from rat liver. J. Biol. Chem. 249, 310315.
  • Kieran M. W. (2005) Anti-angiogenic therapy in pediatric neuro-oncology. J. Neurooncol. 75, 327334.
  • Kitakata H., Nemoto-Sasaki Y., Takahashi Y., Kondo T., Mai M. and Mukaida N. (2002) Essential roles of tumor necrosis factor receptor p55 in liver metastasis of intrasplenic administration of colon 26 cells. Cancer Res. 62, 66826687.
  • Koochekpour S., Merzak A. and Pilkington G. J. (1996) Vascular endothelial growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells in vitro. Cancer Lett. 102, 209215.
  • Ladisch S., Kitada S. and Hays E. F. (1987) Gangliosides shed by tumor cells enhance tumor formation in mice. J. Clin. Invest 79, 18791882.
  • Lang Z., Guerrera M., Li R. and Ladisch S. (2001) Ganglioside GD1a enhances VEGF-induced endothelial cell proliferation and migration. Biochem. Biophys. Res. Commun. 282, 10311037.
  • Lee J. W., Bae S. H., Jeong J. W., Kim S. H. and Kim K. W. (2004) Hypoxia-inducible factor (HIF-1) alpha: its protein stability and biological functions. Exp. Mol. Med. 36, 112.
  • Leon S. P., Folkerth R. D. and Black P. M. (1996) Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 77, 362372.
  • Liu Y., Li R. and Ladisch S. (2004) Exogenous ganglioside GD1a enhances epidermal growth factor receptor binding and dimerization. J. Biol. Chem. 279, 36 48136 489.
  • Maity A., Pore N., Lee J., Solomon D. and O'Rourke D. M. (2000) Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3′-kinase and distinct from that induced by hypoxia. Cancer Res. 60, 58795886.
  • Manfredi M. G., Lim S., Claffey K. P. and Seyfried T. N. (1999) Gangliosides influence angiogenesis in an experimental mouse brain tumor. Cancer Res. 59, 53925397.
  • McKallip R., Li R. and Ladisch S. (1999) Tumor gangliosides inhibit the tumor-specific immune response. J. Immunol. 163, 37183726.
  • Meuillet E. J., Mania-Farnell B., George D., Inokuchi J. I. and Bremer E. G. (2000) Modulation of EGF receptor activity by changes in the GM3 content in a human epidermoid carcinoma cell line, A431. Exp. Cell Res. 256, 7482.
  • Miljan E. A. and Bremer E. G. (2002) Regulation of growth factor receptors by gangliosides. Sci. STKE 160, RE15.
  • Mukherjee P., El-Abbadi M. M., Kasperzyk J. L., Ranes M. K. and Seyfried T. N. (2002) Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model. Br. J. Cancer 86, 16151621.
  • Mukherjee P., Abate L. E. and Seyfried T. N. (2004) Antiangiogenic and proapoptotic effects of dietary restriction on experimental mouse and human brain tumors. Clin. Cancer Res. 10, 56225629.
  • Noll E. N., Lin J., Nakatsuji Y., Miller R. H. and Black P. M. (2001) GM3 as a novel growth regulator for human gliomas. Exp. Neurol. 168, 300309.
  • Olshefski R. and Ladisch S. (1996) Intercellular transfer of shed tumor cell gangliosides. FEBS Lett. 386, 1114.
  • Parikh A. A., Liu W. B., Fan F., Stoeltzing O., Reinmuth N., Bruns C. J., Bucana C. D., Evans D. B. and Ellis L. M. (2003) Expression and regulation of the novel vascular endothelial growth factor receptor neuropilin-1 by epidermal growth factor in human pancreatic carcinoma. Cancer 98, 720729.
  • Podar K., Tai Y. T., Davies F. E. et al. (2001) Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration. Blood 98, 428435.
  • Ranes M. K., El-Abbadi M., Manfredi M. G., Mukherjee P., Platt F. M. and Seyfried T. N. (2001) N-butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours. Br. J. Cancer 84, 11071114.
  • Sango K., Johnson O. N., Kozak C. A. and Proia R. L. (1995) beta-1,4-N-Acetylgalactosaminyltransferase involved in ganglioside synthesis: cDNA sequence, expression, and chromosome mapping of the mouse gene. Genomics 27, 362365.
  • Semenza G. L. (2000) HIF-1: using two hands to flip the angiogenic switch. Cancer Metastasis Rev. 19, 5965.
  • Seyfried T. N., Yu R. K., Saito M. and Albert M. (1987) Ganglioside composition of an experimental mouse brain tumor. Cancer Res. 47, 35383542.
  • Seyfried T. N., El-Abbadi M. and Roy M. L. (1992) Ganglioside distribution in murine neural tumors. Mol. Chem. Neuropathol. 17, 147167.
  • Seyfried T. N., Novikov A. M., Irvine R. A. and Brigande J. V. (1994) Ganglioside biosynthesis in mouse embryos: sialyltransferase IV and the asialo pathway. J. Lipid Res. 35, 9931001.
  • Seyfried T. N., El-Abbadi M., Ecsedy J. A., Bai H. W. and Yohe H. (1996) Influence of host cell infiltration on the glycolipid content of mouse brain tumors. J. Neurochem. 66, 20262033.
  • Soker S., Takashima S., Miao H. Q., Neufeld G. and Klagsbrun M. (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92, 735745.
  • Walton K. M. and Schnaar R. L. (1986) Ganglioside glycosyltransferase assay using ion-exchange chromatography. Anal. Biochem. 152, 154159.
  • Wang X. Q., Sun P. and Paller A. S. (2002) Ganglioside modulation regulates epithelial cell adhesion and spreading via gangliosidespecific effects on signaling. J. Biol. Chem. 277, 40 41040 419.
  • Weidner N., Semple J. P., Welch W. R. and Folkman J. (1991) Tumor angiogenesis and metastasis – correlation in invasive breast carcinoma. N. Engl. J. Med. 324, 18.
  • Yates A. J. and Rampersaud A. (1998) Sphingolipids as receptor modulators. Ann. NY Acad. Sci. 845, 5772.
  • Yohe H. C., Coleman D. L. and Ryan J. L. (1985) Ganglioside alterations in stimulated murine macrophages. Biochim. Biophys. Acta 818, 8186.
  • Yu R. K., Bieberich E., Xia T. and Zeng G. (2004) Regulation of ganglioside biosynthesis in the nervous system. J. Lipid Res. 45, 783793.
  • Yusuf H. K., Pohlentz G. and Sandhoff K. (1984) Ganglioside biosynthesis in Golgi apparatus: new perspectives on its mechanism. J. Neurosci. Res. 12, 161178.
  • Yusuf H. K. M., Schwarzmann G., Pohlentz G. and Sandhoff K. (1987) Oligosialogangliosides inhibit GM2- and GD3-synthesis in isolated Golgi vesicles from rat liver. Biol. Chem. Hoppe-Seyler 368, 455462.
  • Zagzag D., Zhong H., Scalzitti J. M., Laughner E., Simons J. W. and Semenza G. L. (2000) Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer 88, 26062618.
  • Zeng G., Gao L., Birkle S. and YuR. K. (2000) Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production. Cancer Res. 60, 66706676.
  • Zhou Q., Hakomori S., Kitamura K. and Igarashi Y. (1994) GM3 directly inhibits tyrosine phosphorylation and de-N-acetyl-GM3 directly enhances serine phosphorylation of epidermal growth factor receptor, independently of receptor–receptor interaction. J. Biol. Chem. 269, 19591965.
  • Ziche M., Alessandri G. and Gullino P. M. (1989) Gangliosides promote the angiogenic response. Laboratory Invest. 61, 629634.
  • Ziche M., Morbidelli L., Alessandri G. and Gullino P. M. (1992) Angiogenesis can be stimulated or repressed in vivo by a change in GM3: GD3 ganglioside ratio. Laboratory Invest. 67, 711715.
  • Zimmerman H. M. and Arnold H. (1941) Experimental brain tumors: I. tumors produced with methylcholanthrene. Cancer Res. 1, 919938.